JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB287901

Anti-EZH2 抗体 [EPR24902-112] - BSA and Azide free

Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free

Be the first to review this product! Submit a review

|

(0 Publication)

Knockout Tested Rabbit Recombinant Monoclonal KMT6 / EZH2 antibody. Carrier free. Suitable for WB, I-ELISA and reacts with Human, Mouse, Synthetic peptide samples.

別名を表示する

KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, Lysine N-methyltransferase 6

4 Images
Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)

This data was developed using ab287893, the same antibody clone in a different buffer formulation.

ab287893 was shown to specifically react with EZH2 (pT345) in untreated Wild-type HAP1, HeLa and NIH/3T3 (Figure A). After treatment with 150 units alkaline phosphatase for 1 hour at 37°C, no band was observed (Figure B). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (<a href='/products/primary-antibodies/ezh2-antibody-epr24902-112-ab287893'>ab287893</a>) at 1/1000 dilution

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

EZH2 knockout HAP1 cell lysate​ at 20 µg

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

NIH/3T3 cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)

This data was developed using ab287893, the same antibody clone in a different buffer formulation.

ab287893 was shown to specifically react with EZH2 (pT345) in HEK-293. The signal was significantly reduced after blocking with 1µg/ml histone-lysine N-methyltransferase EZH2 peptide (pT345). Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (<a href='/products/primary-antibodies/ezh2-antibody-epr24902-112-ab287893'>ab287893</a>) at 1/1000 dilution

Lane 1:

HEK-293 cell lysate at 20 µg

Lane 2:

HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (unmodified) at 1µg/ml​ at 20 µg

Lane 3:

HEK-293 cell lysate with histone-lysine N-methyltransferase EZH2 peptide (pT345) at 1µg/ml at 20 µg

Secondary

Lanes 1 - 3:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 3:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)
  • WB

Supplier Data

Western blot - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)

This data was developed using ab287893, the same antibody clone in a different buffer formulation.

ab287893 was shown to specifically react with EZH2 (pT345) in HeLa and NIH/3T3. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T). ab287893 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilutions, respectively. Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.​

All lanes:

Western blot - Anti-EZH2 antibody [EPR24902-112] (<a href='/products/primary-antibodies/ezh2-antibody-epr24902-112-ab287893'>ab287893</a>) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 20 µg

Lane 2:

NIH/3T3 cell lysate​ at 20 µg

Secondary

Lanes 1 - 2:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 2:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 98 kDa,37 kDa

false

Indirect ELISA - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)
  • I-ELISA

Supplier Data

Indirect ELISA - Anti-EZH2 antibody [EPR24902-112] - BSA and Azide free (AB287901)

This data was developed using ab287893, the same antibody clone in a different buffer formulation.

Indirect ELISA showing the phospho-specificity (pT345) of primary antibody ab287893. Plates were coated with histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 (pT345), histone-lysine N-methyltransferase EZH2 peptide (unmodified) and histone-lysine N-methyltransferase EZH2 peptide (pT487) peptides at 1000 ng/ml. Binding of ab286909 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).​

Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.​

関連する標識済み抗体及び組成の異なる製品 (1)

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR24902-112

アイソタイプ

IgG

キャリアフリー

Yes

交差種

Human, Mouse

アプリケーション

WB, I-ELISA

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Synthetic peptide": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

ab287901 is the carrier free version of ab287893.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
+4°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The Enhancer of Zeste Homolog 2 (EZH2) is an enzymatic component of the polycomb repressive complex 2 (PRC2). Known also as KMT6 EZH2 functions as a histone methyltransferase catalyzing the tri-methylation of histone H3 at lysine 27 (H3K27me3). This methylation activity is important for gene silencing. EZH2 has a molecular mass of approximately 85 kDa and is expressed in various tissues with higher expression often observed in embryonic stem cells and certain adult tissues such as prostate and breast tissue.
Biological function summary

EZH2 plays an important role in chromatin remodeling and transcriptional repression through its integration within the PRC2 complex which includes proteins such as SUZ12 and EED. This complex is involved in maintaining the transcriptional silencing of genes essential for development and differentiation. EZH2's activity regulates cell fate decisions and helps preserve stem cell pluripotency through repression of lineage-specific genes.

Pathways

EZH2 integrates into mechanisms often seen in the regulation of the Wnt and Hedgehog signaling pathways. These pathways are central to developmental processes and cell proliferation. In the Wnt pathway EZH2 interacts with proteins such as β-catenin impacting gene expression involved in cell growth. Similarly within the Hedgehog pathway EZH2 may influence gene regulation through its interaction with GLI transcription factors again affecting cellular proliferation and tissue patterning.

EZH2 has strong associations with cancer particularly in conditions like prostate cancer and lymphomas. Overexpression or mutations in EZH2 contribute to tumorigenesis by promoting aberrant silencing of tumor suppressor genes. In the context of lymphomas mutations in EZH2 can cooperate with alterations in associated proteins like BCL2 to drive oncogenesis. Furthermore therapeutic interventions targeting EZH2 are under investigation highlighting its relevance in disease progression and potential treatment.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2 (PubMed : 22323599, PubMed : 30923826). Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription.
See full target information EZH2

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com